Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Enhanced Perinatal Surveillance—Participating Areas in the United States and Dependent Areas, 2000–2003

HIV/AIDS Surveillance Supplemental Report, Volume 13, Number 4

Contents

Cover

Commentary

Figure and Tables
Figure 1 Location of enhanced perinatal surveillance areas, 2000–2003
Table 1 Number and percentage of HIV-infected pregnant women who gave birth to a live infant, by year of infant’s birth and selected characteristics of mother, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 2 Prenatal care of HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 3 Timing of HIV testing of HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 4 Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 5 Method of delivery for HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 6 Substance use and toxicology screening of HIV-infected women during pregnancy, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 7 Screening of HIV-infected women during pregnancy, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 8 Number and percentage of HIV-infected women with positive test results for selected conditions, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 9 Prenatal care of HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 10 Timing of HIV testing of HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 11 Receipt of antiretroviral therapy by HIV-infected women and HIV exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 12 Method of delivery for HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 13 Substance use and toxicology screening of HIV-infected women during pregnancy, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 14 Type of birth, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 15 Number and percentage of infants receiving prophylaxis against Pneumocystis jiroveci pneumonia, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 16 Number and percentage of infants infected with HIV through mother-to-child transmission, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 17 Birth weight (grams) of children born to HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 18 Gestational age at birth among HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 19 Birth defects in first year of life in children born to HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 20 Number and percentage of HIV-infected women who gave birth to a live infant and received medical treatment reimbursement, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas
Table 21 Type of facility where prenatal care was provided, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas

Technical Notes

 

National HIV/AIDS Strategy Updates

AIDS.gov: Access to U.S. Government HIV / AIDS information

Stay up-to-date with the United States Government at AIDS 2012
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #